SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-001646
Filing Date
2012-02-28
Accepted
2012-02-27 20:18:30
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207475z10-k.htm 10-K 1685599
2 EX-21 a2207475zex-21.htm EX-21 3767
3 EX-23.1 a2207475zex-23_1.htm EX-23.1 5258
4 EX-31.1 a2207475zex-31_1.htm EX-31.1 8927
5 EX-31.2 a2207475zex-31_2.htm EX-31.2 8906
6 EX-32.1 a2207475zex-32_1.htm EX-32.1 5251
7 EX-32.2 a2207475zex-32_2.htm EX-32.2 5238
14 G746503.JPG g746503.jpg GRAPHIC 54041
  Complete submission text file 0001047469-12-001646.txt   14274998

Data Files

Seq Description Document Type Size
8 EX-101.INS uthr-20111231.xml EX-101.INS 1960457
9 EX-101.SCH uthr-20111231.xsd EX-101.SCH 119002
10 EX-101.CAL uthr-20111231_cal.xml EX-101.CAL 159908
11 EX-101.DEF uthr-20111231_def.xml EX-101.DEF 562823
12 EX-101.LAB uthr-20111231_lab.xml EX-101.LAB 1905441
13 EX-101.PRE uthr-20111231_pre.xml EX-101.PRE 847698
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 12644244
SIC: 2834 Pharmaceutical Preparations